![Maria Liminga Björk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maria Liminga Björk is currently the Chairman at Ewald Larsson Eftr.
.
AB. She also holds the position of Chief Research & Development Officer at Olink Holding AB since 2024 and Vice President-President of Research & Development at Olink Proteomics AB since 2023.
Previously, she worked as the Director of Bio Process R&D at Cytiva LLC from 2020 to 2023.
| Unternehmen | Position | Beginn |
|---|---|---|
| OLIK HLDG | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2024 |
Ewald Larsson Eftr. AB
 Ewald Larsson Eftr. AB Real Estate DevelopmentFinance Provides real estate services | Vorsitzender | - |
Olink Proteomics AB
 Olink Proteomics AB Miscellaneous Commercial ServicesCommercial Services Provides commercial physical and biological research and development | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
Cytiva LLC
 Cytiva LLC Pharmaceuticals: MajorHealth Technology Manufactures and sells therapeutics | Corporate Officer/Principal | 02.01.2023 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
Cytiva LLC
Cytiva LLC Pharmaceuticals: MajorHealth Technology Manufactures and sells therapeutics | Health Technology |
Ewald Larsson Eftr. AB
Ewald Larsson Eftr. AB Real Estate DevelopmentFinance Provides real estate services | Finance |
Olink Proteomics AB
Olink Proteomics AB Miscellaneous Commercial ServicesCommercial Services Provides commercial physical and biological research and development | Commercial Services |
Olink Holding AB
 Olink Holding AB BiotechnologyHealth Technology Develops proteomics platform | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
